| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | |
|---|
|
| L | | IP | CI | | Exelon Patch 5 | 30 plaster(s) | 40.73 | 60.35 | 10 % | | Transdermal patch: Rivastigminum 9 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| L | | IP | CI | | Exelon Patch 10 | 30 plaster(s) | 40.73 | 60.35 | 10 % | | Transdermal patch: Rivastigminum 18 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| L | | IP | CI | | Exelon Patch 10 | 60 plaster(s) | 81.46 | 104.25 | 10 % | | Transdermal patch: Rivastigminum 18 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| L | | IP | CI | | Exelon Patch 15 | 30 plaster(s) | 40.73 | 60.35 | 10 % | | Transdermal patch: Rivastigminum 27 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| L | | IP | CI | | Exelon Patch 15 | 60 plaster(s) | 81.46 | 104.25 | 10 % | | Transdermal patch: Rivastigminum 27 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| L | | IP | CI | CM | Rivastigmin Patch Sandoz 5 | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 9 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | IP | CI | CM | Rivastigmin Patch Sandoz 10 | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | G |
| L | | IP | CI | CM | Rivastigmin Patch Sandoz 10 | 60 | 69.24 | 91.70 | 10 % | | Transdermal patch: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | IP | CI | CM | Rivastigmin Patch Sandoz 15 | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 27 mg | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | G |
| L | | IP | CI | CM | Rivastigmin Patch Sandoz 15 | 60 | 69.24 | 91.70 | 10 % | | Transdermal patch: Rivastigminum 27 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin Zentiva Patch 4.6
mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 6.9 mg | Helvepharm AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin Zentiva Patch 9.5
mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 13.8 mg | Helvepharm AG | ● B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin Zentiva Patch 9.5
mg/24 h | 2 x 30 | 69.24 | 91.70 | 10 % | | Transdermal patch: Rivastigminum 13.8 mg | Helvepharm AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin Zentiva Patch
13.3 mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermal patch: Rivastigminum 19.2 mg | Helvepharm AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin Zentiva Patch
13.3 mg/24 h | 2 x 30 | 69.24 | 91.70 | 10 % | | Transdermal patch: Rivastigminum 19.2 mg | Helvepharm AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin-Mepha Patch 4.6
mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermale Pflaster: Rivastigminum 6.4 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin-Mepha Patch 9.5
mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermale Pflaster: Rivastigminum 12.8 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin-Mepha Patch 9.5
mg/24 h | 2 x 30 | 69.24 | 91.70 | 10 % | | Transdermale Pflaster: Rivastigminum 12.8 mg | Mepha Pharma AG | ● B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin-Mepha Patch
13.3 mg/24 h | 30 | 34.62 | 54.05 | 10 % | | Transdermale Pflaster: Rivastigminum 19.2 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | CI | | Rivastigmin-Mepha Patch
13.3 mg/24 h | 2 x 30 | 69.24 | 91.70 | 10 % | | Transdermale Pflaster: Rivastigminum 19.2 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| L | | IP | CI | | Exelon 1,5 mg - T | 28 Capsule(s) | 22.42 | 40.80 | 10 % | | Capsules: Rivastigminum 1.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 1,5 mg - T | 56 Capsule(s) | 40.18 | 60.10 | 10 % | | Capsules: Rivastigminum 1.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 1,5 mg - T | 112 Capsule(s) | 88.12 | 112.25 | 10 % | | Capsules: Rivastigminum 1.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 3 mg - T | 28 Capsule(s) | 22.42 | 40.80 | 10 % | | Capsules: Rivastigminum 3 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 3 mg - T | 56 Capsule(s) | 40.18 | 60.10 | 10 % | | Capsules: Rivastigminum 3 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 3 mg - T | 112 Capsule(s) | 88.12 | 112.25 | 10 % | | Capsules: Rivastigminum 3 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 4,5 mg - T | 28 Capsule(s) | 22.42 | 40.80 | 10 % | | Capsules: Rivastigminum 4.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 4,5 mg - T | 112 Capsule(s) | 88.12 | 112.25 | 10 % | | Capsules: Rivastigminum 4.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 6 mg - T | 28 Capsule(s) | 22.42 | 40.80 | 10 % | | Capsules: Rivastigminum 6 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 6 mg - T | 112 Capsule(s) | 88.12 | 112.25 | 10 % | | Capsules: Rivastigminum 6 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Exelon 2 mg/ml | 120 ml | 62.35 | 84.25 | 10 % | | Solution (oral): Rivastigminum 2 mg/ml | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Rivasur due volte alla
settimana 4,6 mg/24 ore | 8 | 32.31 | 51.55 | 10 % | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 25.92 mg | Zambon Svizzera SA | B / SL | FB | G |
| L | | IP | CI | | Rivasur due volte alla
settimana 4,6 mg/24 ore | 16 | 64.62 | 86.70 | 10 % | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 25.92 mg | Zambon Svizzera SA | B / SL | FB | G |
| L | | IP | CI | | Rivasur due volte alla
settimana 9,5 mg/24 ore | 8 | 32.31 | 51.55 | 10 % | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 51.84 mg | Zambon Svizzera SA | B / SL | FB | G |
| L | | IP | CI | | Rivasur due volte alla
settimana 9,5 mg/24 ore | 16 | 64.62 | 86.70 | 10 % | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 51.84 mg | Zambon Svizzera SA | B / SL | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco 4,6
mg/24 h (9mg) | 30 | | | k.A. | | Transdermal patch: Rivastigminum 9 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco 9,5
mg/24 h (18 mg) | 30 | | | k.A. | | Transdermal patch: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco 9,5
mg/24 h (18 mg) | 60 | | | k.A. | | Transdermal patch: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco
13,3 mg/24 h (23,1 mg) | 30 | | | k.A. | | Transdermal patch: Rivastigminum 23.1 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco
13,3 mg/24 h (23,1 mg) | 60 | | | k.A. | | Transdermal patch: Rivastigminum 23.1 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
